Bed Bath & Beyond Inc.
BBBY · NYSE
12/31/2024 | 12/31/2023 | 2/25/2023 | 2/26/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.01 | 0.19 | 0.21 |
| FCF Yield | -84.84% | -5.25% | -150.47% | -14.50% |
| EV / EBITDA | -0.43 | -3.72 | -46.34 | 12.70 |
| Quality | ||||
| ROIC | -93.93% | -29.07% | 3.90% | 13.90% |
| Gross Margin | 19.54% | 18.95% | 22.15% | 21.99% |
| Cash Conversion Ratio | 0.67 | 0.06 | 0.28 | -0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -10.25% | -17.26% | -8.20% | 23.61% |
| Free Cash Flow Growth | -206.16% | 95.20% | -293.62% | -285.20% |
| Safety | ||||
| Net Debt / EBITDA | 0.53 | 1.22 | 27.65 | -3.07 |
| Interest Coverage | -86.69 | -67.03 | 0.00 | 199.77 |
| Efficiency | ||||
| Inventory Turnover | 97.21 | 97.03 | 230.15 | 418.61 |
| Cash Conversion Cycle | -22.89 | -25.49 | -16.81 | -18.03 |